|William Leslie, MD MSc FRCPC
Dr. Leslie is a Professor of Medicine and Radiology at the University of Manitoba. He obtained his specialty training from the University of Manitoba and McGill University, qualifying in Internal Medicine in 1989 and in Nuclear Medicine in 1990. He is clinically active in nuclear medicine and thyroid cancer, and has over 200 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing and other nuclear diagnostic techniques including PET scanning.
He is currently Chair of the Scientific Advisory Council, co-led the "2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoprosis in Canada", on the Board of the International Society for Clinical Densitometry, Director of the Manitoba Bone Density Program and Co-Director of the Winnipeg PET Imagaing Centre.
Dr. Sandor Demeter
Dr. Demeter received his BSc (1986) and MD (1989) from the University of Saskatchewan. Thereafter he obtained his Canadian Royal College Fellowship (FRCPC) with certification in Community Medicine (1994), and a Masters of Health Science in Community Health and Epidemiology (1993), both from the University of Toronto.
He also has Canadian Royal College certification in Nuclear Medicine (2002), as well as a Masters of Science Degree (2004), both from the University of Alberta.
He currently is the Section Head of Nuclear Medicine at the Health Sciences Centre in Winnipeg MB as well as the Co-Director of the Winnipeg Great West Life Positron Emission Tomography program. He is an Associate Professor with the Department of Radiology (primary) and Community Health Sciences. His main areas of research are health technology assessment, health policy, and health economics with an emphasis on diagnostic imaging.
Dr. Bohdan Bybel
|Daniel P. Levin, BSc, MD, FRCPC
Dr. Daniel Levin is an assistant professor in the departments of Radiology and Child Health at the University of Manitoba. He is chair of The Specialty Committee in Nuclear Medicine of The Royal College of Physicians and Surgeons of Canada. He is head of the Section of Nuclear Medicine at Grace General Hospital, and a staff Nuclear Medicine physician at Health Sciences Centre.
Dr. Levin’s clinical work is in Nuclear Medicine and PET, with special interest and expertise in pediatric Nuclear Medicine. He works closely with pediatric endocrinology in radioactive iodine treatment of hyperthyroid and thyroid cancer patients, and is involved in treatment of adult thyroid cancer patients.
Dr. Levin attended The University of Manitoba Medical School, worked as an emergency physician at the Victoria General Hospital, and pursued Nuclear Medicine specialty training at The University of Manitoba, McGill University, and The University of Montreal.
|Dr. Sheryl Stern
Dr. Sheryl Stern is an Assistant Professor of Nuclear Medicine at the University of Manitoba, on staff at the Health Sciences Centre in Winnipeg. She is currently Director of the Nuclear Medicine Resident Training Program. Dr. Stern obtained her specialty in Nuclear Medicine at the University of Manitoba in 1992. She has a special interest in Probe guided surgery, particularly in the areas of Sentinel node biopsy and parathyroid surgery.
|Andrew Goertzen, Ph.D.
Dr. Andrew L. Goertzen is the Coordinator of the PET-CT Program, providing physics support for the PET-CT Program, and is an Assistant Professor in the Department of Radiology at the University of Manitoba. He obtained his B.Sc.(Hons.) in Physics from the University of Manitoba in 1998 and then obtained his M.S. in 2001 and Ph.D. in 2003 in Biomedical Physics from the University of California, Los Angeles. He is active in PET physics research with ongoing projects investigating the performance of both clinical and pre-clinical PET systems.
|Kennedy Mang'era, Ph.D.
Dr Kennedy Mang'era is Assistant Director for the Radiopharmacy at the Health Sciences Centre and is Assistant Professor of Radiology and of Pharmacy at the University of Manitoba. He is a Bachelor of Pharmacy graduate of the University of Nairobi (1988) and has specialist training in Radiopharmaceutical Sciences from the Katholieke Universiteit Leuven in Belgium (Masters, 1995 and PhD, 1999). He has post-doctoral research experience from the University of Massachussetts in Worchester where he worked with morpholino oligonucleotides and the pre-targeting approach to tumour diagnosis and therapy. Current research focus is in enhanced targeting of, and delivery to, tumor sites using anticancer agents that are conjugated to polymeric molecules.
Dr Mang'era is active within the Canadian Association of Radiopharmaceutical Sciences (currently Secretary) and is Associate Editor of the Photon (a publication of the Canadian Association of Nuclear Medicine).